How Many mg of Melatonin Is Safe to Take?

For most adults using melatonin as a sleep aid, doses between 0.5 and 5 mg are considered safe, and recent evidence suggests the sleep-promoting effect plateaus around 4 mg per day. That range covers the vast majority of people who grab a bottle off the shelf, but the “right” dose depends on your age, what you’re trying to treat, and which medications you take. The picture gets more complicated when you factor in the wild inconsistency of what’s actually inside supplement capsules.

The Dose That Peaks for Sleep

A 2024 dose-response meta-analysis of randomized controlled trials found that melatonin gradually reduces the time it takes to fall asleep and increases total sleep time, with the effect peaking at about 4 mg per day. The researchers also found that taking melatonin roughly three hours before your desired bedtime outperformed the more common habit of taking it 30 minutes before bed.¹ That 4 mg ceiling is worth remembering: doubling or tripling the dose past that point doesn’t help you sleep more, and it raises the odds of grogginess the next morning.

For jet lag specifically, a Cochrane review found that doses between 0.5 and 5 mg were similarly effective at reducing symptoms, though people fell asleep faster and slept better after 5 mg compared to 0.5 mg. Doses above 5 mg didn’t appear to add any benefit. The review also noted that slow-release melatonin at 2 mg was relatively ineffective for jet lag, suggesting that a short-lived higher peak in blood concentration works better for resetting your clock after travel.²

So the practical takeaway for a healthy adult is straightforward: start at 0.5 to 1 mg, move up to 3 to 5 mg if needed, and don’t assume that a 10 mg tablet will knock you out twice as fast as a 5 mg one. The receptor system that melatonin acts on saturates at relatively modest doses, and piling on more milligrams mainly extends how long supra-normal levels linger in your blood.

Why Older Adults Should Dose Lower

If you’re over 65, the math changes. Your liver and kidneys clear melatonin more slowly, and your body composition shifts in ways that alter how the hormone distributes through your system. Studies have found that peak blood concentrations of melatonin after the same oral dose can be dramatically higher in older adults, with some reports showing levels up to about two and a half times greater than in adults under 45.³ That means a 5 mg pill might behave in your body more like a 10 mg pill would in a younger person.

Research comparing high doses (3 to 4 mg) with low doses (0.3 to 0.4 mg) in older adults found that the higher doses kept blood levels well above normal for more than ten hours. At those sustained supra-physiological levels, melatonin actually lost its effectiveness on sleep, while the lower doses preserved it.⁴ A systematic review of dosing in older adults concluded that the lowest possible dose of immediate-release melatonin, in the range of 0.3 to 1 mg taken about an hour before bed, best mimics the body’s natural circadian rhythm and avoids prolonged high blood levels the following day.⁵

Next-day drowsiness, unsteadiness, and a foggy feeling on waking are the practical risks here. For older adults already at elevated fall risk, that morning hangover from a melatonin dose that was too high is not trivial.

Side Effects You Might Actually Notice

Melatonin’s side-effect profile is genuinely mild compared to prescription sleep medications. A systematic review looking at adverse events across sleep disorder trials found that the most commonly reported problems were daytime sleepiness (about 1.7% of participants), headache, dizziness, and a slight drop in body temperature, each occurring in under 1% of users. Serious or clinically significant events were rare and included things like agitation, mood swings, nightmares, and palpitations. Most side effects either resolved on their own within a few days or disappeared immediately when people stopped taking melatonin.⁶

Even at doses far beyond what anyone would take for sleep, melatonin has shown a surprisingly clean safety record. A review of both animal and human data concluded that short-term use is safe even at extreme doses, with only mild effects like dizziness, headache, nausea, and sleepiness reported. No studies identified any serious adverse effects caused by exogenous melatonin.⁷ A separate meta-analysis focused on higher-dose regimens found that melatonin did not increase serious adverse events or study withdrawals, though it did raise the rate of minor side effects like drowsiness, headache, and dizziness by about 40% compared to placebo.⁸

To put a finer point on it: clinicians in one study prescribed melatonin at doses of 40 to 200 mg daily to elderly patients with sleep disturbances and other health conditions. Even in that range, no clinically relevant adverse effects were observed, just occasional headaches or dizziness.⁹ Nobody is recommending 200 mg for insomnia, but the point is that melatonin’s lethal-dose ceiling appears to be extremely high, and the substance has a wide margin of safety in the short term.

What’s Actually in the Bottle

Here is where things get genuinely alarming. Because melatonin is sold as a dietary supplement in the United States, it doesn’t go through the same manufacturing and testing oversight that a prescription drug would. When researchers have tested what’s actually inside melatonin products, the results have been startling. One Canadian analysis of commercial melatonin supplements found that the actual melatonin content ranged from 83% less than the label claimed to 478% more. Even different lots of the same product varied by as much as 465%.¹⁰

A more recent U.S. survey of melatonin dietary supplements found the situation was no better: melatonin content ranged from 0% to 667% of what the label declared.¹¹ That means a pill labeled “3 mg” could contain virtually nothing or could deliver closer to 20 mg. This is the real-world context that makes dosing advice somewhat frustrating: you can aim for 1 mg, but you have limited certainty about what you’re actually getting. If you find that a new brand hits you much harder or doesn’t work at all compared to your old one, inconsistent manufacturing is a plausible explanation.

Choosing products that carry a third-party testing seal (USP, NSF, or ConsumerLab) doesn’t guarantee perfection, but it substantially improves your odds of getting something close to the labeled dose.

Children, Accidental Ingestion, and the Gummy Problem

Melatonin use among children has surged, and so have accidental overdoses. Over a ten-year period, U.S. poison control centers logged more than 260,000 pediatric melatonin ingestions, and the annual number increased by 530%. By 2021, melatonin accounted for nearly 5% of all pediatric ingestions reported, up from 0.6% in 2012. Most of these cases involved unintentional ingestion by children age five and under. Five children required mechanical ventilation, and two died.¹²

The rise in pediatric exposures tracks closely with the explosion of melatonin gummies, which look and taste like candy. If you keep melatonin in the house and have small children, treat it with the same respect you’d give any medication: child-resistant caps, stored out of reach.

For intentional pediatric use, the evidence base is thinner than many parents realize. Studies showing that melatonin is generally safe and well-tolerated in children have been conducted largely in kids with neurodevelopmental disorders and insomnia. A comparable body of evidence for typically developing children is lacking, and long-term prospective studies on adverse effects have not been done.¹³ That doesn’t mean melatonin is dangerous for healthy kids, but it does mean the confident reassurances floating around parent forums outpace the actual data.

Does Melatonin Affect Puberty?

This is a common worry for parents giving melatonin to children over months or years. Melatonin is involved in reproductive hormone signaling, and animal studies have shown that it can influence puberty-related hormones. In mice, melatonin administration accelerated puberty onset by promoting certain reproductive hormone pathways.¹⁴ That finding understandably raises eyebrows, but mouse hormone systems are not human hormone systems, and the doses and exposures differ enormously.

The human data so far has been reassuring. A two-year study of prolonged-release melatonin in children with autism spectrum disorder found that changes in weight, height, body mass index, and pubertal development (assessed by a physician using standard staging) were all within normal ranges, with no evidence of delay.¹⁵ Still, researchers have called for long-term randomized trials in prepubertal children who don’t have neurodevelopmental conditions, specifically to look at whether melatonin interacts with kisspeptin, a neuropeptide involved in triggering puberty.¹⁶ Until those trials happen, the honest answer is that two years of data look fine, but we can’t yet rule out subtler effects over longer periods.

Immediate-Release vs Sustained-Release Formulations

This distinction matters more than many people realize, and the wrong formulation for your situation can make melatonin feel either useless or excessively sedating. A head-to-head pharmacokinetic study in healthy adults found that immediate-release melatonin produced a peak blood concentration roughly twice as high as a sustained-release capsule at the same dose, and it reached that peak faster. The sustained-release version, on the other hand, maintained higher blood levels in the four-to-eight-hour window after dosing, with concentrations one to three times greater during that later phase.¹⁷

The practical implication: if your problem is falling asleep, immediate-release gives you a quick spike that signals “nighttime” to your brain. If your problem is waking up at 3 a.m. and not getting back to sleep, sustained-release keeps levels elevated longer. For jet lag, immediate-release appears to work better, as the Cochrane review noted. The key is matching the release profile to the problem you’re trying to solve, not just matching the milligram count.

Tolerance, Dependence, and Your Body’s Own Supply

One of the more persistent worries about taking melatonin regularly is that it will suppress your body’s own production or create dependence. The evidence says neither happens. A review of chronic melatonin administration found that exogenous melatonin does not appear to reduce endogenous production, and no withdrawal symptoms have been reported when people stop taking it.¹⁸

A controlled trial in hypertensive patients taking beta-blockers (a group whose natural melatonin production is already suppressed by their medication) found that three weeks of nightly melatonin improved sleep quality without any sign of tolerance. When supplementation stopped, there was no rebound insomnia. If anything, a positive carryover effect was observed, meaning sleep quality remained somewhat improved even after melatonin was discontinued.¹⁹ This is a genuine advantage over many prescription sleep aids, where rebound insomnia and dose escalation are real concerns.

Drug Interactions Worth Knowing About

Melatonin is metabolized primarily by liver enzymes in the CYP1A2 pathway. Drugs that inhibit or induce that enzyme can raise or lower your melatonin levels in unpredictable ways. Fluvoxamine (an antidepressant), ciprofloxacin (an antibiotic), and oral contraceptives can all increase melatonin levels, sometimes dramatically. Smoking, which induces CYP1A2, can lower them.

A more specific interaction that deserves attention involves calcium channel blockers, a common class of blood pressure medication. A study of hypertensive patients well controlled on nifedipine found that evening melatonin administration raised blood pressure and heart rate over 24 hours, with systolic pressure increasing by about 6.5 mmHg and diastolic by about 5 mmHg. The researchers hypothesized that melatonin competes with nifedipine at calcium channels, weakening the drug’s blood-pressure-lowering effect.²⁰ If your blood pressure is managed with a calcium channel blocker, this is a conversation to have with your doctor before adding melatonin.

Melatonin and Blood Sugar

Melatonin receptors are present in the pancreas, and there’s been growing interest in whether supplementation affects glucose metabolism. A randomized crossover trial in patients with type 2 diabetes found that three months of melatonin treatment significantly reduced insulin sensitivity compared to placebo.²¹ That’s a result that moves in the wrong direction for someone with diabetes.

The picture isn’t entirely consistent, though. A separate trial in night-shift workers found that twelve weeks of melatonin did not significantly change insulin resistance, blood pressure patterns, or melatonin and cortisol profiles.²² The different results may reflect the different populations studied, or melatonin’s effects on glucose could depend on timing relative to meals and light exposure. Either way, if you have diabetes or prediabetes and take melatonin regularly, monitoring blood sugar more closely when you start is reasonable.

Pregnancy and Breastfeeding

Melatonin crosses the placenta and is present in breast milk, which naturally makes people cautious. Animal studies have raised some concerns, but a scoping review of human studies found that melatonin use during pregnancy and breastfeeding appears to be probably safe.²³ “Probably safe” is a fair reflection of the evidence: the data we have is reassuring, but the studies are small and few. Most clinicians would advise pregnant or breastfeeding women to discuss melatonin use with their provider rather than self-prescribing, and that seems like sound advice given the limited data.

Immune Modulation and Autoimmune Conditions

Melatonin is not just a sleep molecule. It actively modulates immune function, and this cuts both ways. It has anti-inflammatory properties that may be beneficial in many contexts, but it also displays pro-inflammatory effects, particularly in immune cell studies, that could be harmful if you have an autoimmune disease.²⁴

In animal models of autoimmune disease, melatonin has shown benefit in several conditions but worsened rheumatoid arthritis. Human clinical data exists for rheumatoid arthritis and ulcerative colitis, and melatonin’s ability to shift the balance of immune cell subtypes and cytokine production is well documented.²⁵ If you have an autoimmune condition, especially rheumatoid arthritis, this is another area where checking with a specialist before starting regular melatonin use is genuinely warranted rather than boilerplate caution. The immune effects are real and dose-dependent, and they don’t always move in a helpful direction.